Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3097667 23 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Both early-onset and late-onset ventilator-associated pneumonia are
caused mainly by potentially multiresistant bacteria
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objective: To compare the causative pathogens of early-onset and
late-onset ventilator-associated pneumonia (VAP) diagnosed by
bronchoalveolar lavage quantitative cultures. Most previous reports have
been based on endotracheal aspirate cultures and gave uncertain
findings. Design: Prospective evaluation of consecutive patients with
clinical suspicion for VAP. Setting: Multidisciplinary intensive care
unit of a university hospital. Patients and participants: During a
3-year period 473 patients with clinical suspicion of VAP entered the
study. Diagnosis of VAP was confirmed by cultures of bronchoalveolar
lavage (>10(4) cfu/ml) specimens in 408 patients. Interventions:
Protected bronchoalveolar lavage samples were taken. Initial antibiotic
therapy was modified upon bronchoalveolar lavage culture results.
Measurements and results: Among 408 patients 191 had early-onset (<7
days mechanical ventilation) and 217 late-onset (>= 7 days) VAP.
Potentially multiresistant bacteria, mainly Pseudomonas aeruginosa and
methicillin-resistant Staphylococcus aureus (MRSA), were the most
commonly isolated pathogens in both types of VAP. No difference was
noted in the contribution of potentially multiresistant pathogens (79%
vs. 85%), P. aeruginosa (42% vs. 47%), or MRSA (33% vs. 30%)
between early-onset and late-onset VAP. Initial antibiotic therapy was
modified in 58% of early-onset VAP episodes and in 36% of late-onset
VAP episodes. No difference in mortality was found between the two types
of VAP. Conclusions: Both early-onset and late-onset VAP were mainly
caused by potentially multiresistant bacteria, most commonly P.
aeruginosa and MRSA. Antimicrobial agents against these pathogens should
be prescribed empirically, at least in our institution.
Έτος δημοσίευσης:
2005
Συγγραφείς:
Giantsou, E
Liratzopoulos, N
Efraimidou, E
Panopoulou, M and
Alepopoulou, E
Kartali-Ktenidou, S
Minopoulos, GI and
Zakynthinos, S
Manolas, KI
Περιοδικό:
Intensive Care Medicine Experimental
Εκδότης:
Springer-Verlag
Τόμος:
31
Αριθμός / τεύχος:
11
Σελίδες:
1488-1494
Λέξεις-κλειδιά:
ventilator-associated pneumonia; resistant bacteria; mechanical
ventilation; bronchoalveolar lavage
Επίσημο URL (Εκδότης):
DOI:
10.1007/s00134-005-2697-y
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.